Date of Award
2019
Embargo Period
6-24-2024
Document Type
Dissertation - MUSC Only
Degree Name
Doctor of Philosophy (PhD)
Department
Pathology and Laboratory Medicine
College
College of Graduate Studies
First Advisor
Amanda C. LaRue
Second Advisor
James J. Cray
Third Advisor
Victoria J. Findlay
Fourth Advisor
Meenal Mehrotra
Fifth Advisor
Robin Muise-Helmericks
Sixth Advisor
Vincent D. Pellegrini
Abstract
Musculoskeletal extremity injuries are a major cause of morbidity in US populations, including Veterans and seniors. Long bone fracture repair requires osteogenic progenitor cells capable of producing mature osteocytes that supply the cellular and granular components of remodeling bone. Our previously published work demonstrates that murine hematopoietic stem cells (HSC) are a novel source of osteogenic progenitor cells. Early studies demonstrated the osteogenic potential of human bone marrow-derived adherent cells in vitro and implicated IGF2 as a novel pro-osteogenic factor in these cells, through activation of endogenous phosphatase SHP2. Building on this foundation, I hypothesized that human HSC-derived osteogenic progenitor cells are capable of differentiating into mature osteocytes, participating in fracture repair, and that SHP2 inhibition would prevent IGF-mediated potentiation of osteoblastic differentiation. I demonstrate the osteogenic capacity of HSCs by immunohistochemical evidence of human-derived osteocytes in mice. In vitro studies demonstrated enhanced mineralization of human bone marrow-derived adherent cells treated with IGF2. This enhanced mineralization was secondary to IGF2-induced activation of mitogenic AKT and ERK signaling. The enhanced mineralization after IGF2 treatment required SHP2 function. Genetic and pharmacological SHP2 inhibition reduced osteoblastic mineralization in vitro. These studies underscore the need to evaluate the effect of SHP2 inhibition on skeletal health as targeted SHP2 inhibitors enter clinical practice.
Recommended Citation
Jensen, Nathaniel Robert, "Osteoblastic Plasticity of Hematopoietic Cells and Modulation of Osteoblastic Differentiation by SHP2" (2019). MUSC Theses and Dissertations. 729.
https://medica-musc.researchcommons.org/theses/729
Rights
All rights reserved. Copyright is held by the author.